Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to main study - Strowitzki, Thomas (BioMed Central, 2016)
Wissenschaftlicher Aufsatz aus: Reproductive Biology and Endocrinology, 14 (2016), Nr. 31. pp. 1-14. ISSN 1477-7827